DE69818823D1 - Dipohosphonsäuresalze für die behandlung von osteoporose - Google Patents

Dipohosphonsäuresalze für die behandlung von osteoporose

Info

Publication number
DE69818823D1
DE69818823D1 DE69818823T DE69818823T DE69818823D1 DE 69818823 D1 DE69818823 D1 DE 69818823D1 DE 69818823 T DE69818823 T DE 69818823T DE 69818823 T DE69818823 T DE 69818823T DE 69818823 D1 DE69818823 D1 DE 69818823D1
Authority
DE
Germany
Prior art keywords
osteoporosis
dipohosphonic
treatment
acid salts
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69818823T
Other languages
English (en)
Other versions
DE69818823T2 (de
Inventor
Gulik Fred Van
Antonio Parente
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipotec SA
Eurodrug Ltd
Original Assignee
Lipotec SA
Eurodrug Ltd
Geange Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec SA, Eurodrug Ltd, Geange Ltd filed Critical Lipotec SA
Publication of DE69818823D1 publication Critical patent/DE69818823D1/de
Application granted granted Critical
Publication of DE69818823T2 publication Critical patent/DE69818823T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
DE69818823T 1997-07-09 1998-07-08 Dipohosphonsäuresalze für die behandlung von osteoporose Expired - Fee Related DE69818823T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI971628 1997-07-09
IT97MI001628A IT1293305B1 (it) 1997-07-09 1997-07-09 Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi
PCT/EP1998/004238 WO1999002539A1 (en) 1997-07-09 1998-07-08 Diphosphonic acid salts for the treatment of osteoporosis

Publications (2)

Publication Number Publication Date
DE69818823D1 true DE69818823D1 (de) 2003-11-13
DE69818823T2 DE69818823T2 (de) 2004-05-06

Family

ID=11377528

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69818823T Expired - Fee Related DE69818823T2 (de) 1997-07-09 1998-07-08 Dipohosphonsäuresalze für die behandlung von osteoporose

Country Status (17)

Country Link
US (1) US6410782B1 (de)
EP (1) EP0994884B1 (de)
JP (1) JP3681637B2 (de)
KR (1) KR100396036B1 (de)
CN (1) CN1161363C (de)
AT (1) ATE251631T1 (de)
AU (1) AU8806798A (de)
BR (1) BR9810561A (de)
CA (1) CA2303210A1 (de)
DE (1) DE69818823T2 (de)
DK (1) DK0994884T3 (de)
ES (1) ES2207853T3 (de)
HU (1) HUP0004679A3 (de)
IL (1) IL133172A (de)
IT (1) IT1293305B1 (de)
PT (1) PT994884E (de)
WO (1) WO1999002539A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
US20080269184A1 (en) * 2004-03-04 2008-10-30 Makoto Yuasa Niosome Having Metal Porphyrin Complex Embedded Therein, Process For Producing The Same And Drug With The Use Thereof
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
FR2926081B1 (fr) * 2008-01-03 2010-02-19 Univ Nantes Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux
EP2266578A4 (de) * 2008-03-18 2011-08-17 Dikovskiy Aleksander Vladimirovich Pharmazeutische zusammensetzung zur prävention und behandlung von knochenresorption unterschiedlicher ätiologie
KR20110079813A (ko) 2008-09-22 2011-07-08 아이시스 이노베이션 리미티드 이미다조〔1,2－α〕피리디닐 비스포스포네이트
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
EP3084483A1 (de) * 2013-12-19 2016-10-26 3M Innovative Properties Company Artikel mit selbstorganisierten schichten mit nanopartikeln mit einer phosphoroberflächenbehandlung
CN106361701B (zh) * 2016-08-31 2019-08-27 上海交通大学 一种脂质体药物载体及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751372A (en) 1971-06-18 1973-08-07 Hercules Inc Scale and corrosion control in circulating water using polyphosphates and organophonic acids
GB1508772A (en) 1975-04-04 1978-04-26 Shell Int Research Biologically active compositions
DD150744A1 (de) 1980-04-02 1981-09-16 Sigurd Wobst Verfahren zur kontinuierlichen herstellung von cycloalkylhydroperoxiden
IT1201087B (it) 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
DE3434667A1 (de) * 1984-09-21 1986-04-03 Henkel KGaA, 4000 Düsseldorf 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
JPS63165457A (ja) 1986-12-27 1988-07-08 Lion Corp 導電性樹脂組成物
JPS63286478A (ja) 1987-05-19 1988-11-24 Lion Corp 導電性塗料組成物
DD273650A1 (de) 1988-07-01 1989-11-22 Robotron Elektronik Verfahren zur chemischen anschlagvernicklung von kupferstrukturen auf dielektrika
HUT63323A (en) 1990-07-13 1993-08-30 Procter & Gamble Composition against dental deposits, comprissing azacycloalkane diphosphonates
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
CA2077312C (en) * 1992-09-01 2000-02-08 Ronald L. Oleka Condensate polisher regenerant system
JPH06100576A (ja) * 1992-09-21 1994-04-12 Kirin Brewery Co Ltd 骨粗鬆症治療剤または予防剤
JP3238304B2 (ja) * 1995-08-11 2001-12-10 三菱重工業株式会社 スケール溶解液
JP3445426B2 (ja) 1995-12-26 2003-09-08 花王株式会社 高吸水性樹脂組成物

Also Published As

Publication number Publication date
US6410782B1 (en) 2002-06-25
JP3681637B2 (ja) 2005-08-10
HUP0004679A2 (hu) 2001-08-28
KR100396036B1 (ko) 2003-08-27
JP2001509510A (ja) 2001-07-24
ATE251631T1 (de) 2003-10-15
ITMI971628A1 (it) 1999-01-09
EP0994884B1 (de) 2003-10-08
DK0994884T3 (da) 2004-02-16
CN1261892A (zh) 2000-08-02
IL133172A0 (en) 2001-03-19
HUP0004679A3 (en) 2002-04-29
IL133172A (en) 2005-03-20
IT1293305B1 (it) 1999-02-16
PT994884E (pt) 2004-02-27
CA2303210A1 (en) 1999-01-21
ITMI971628A0 (de) 1997-07-09
KR20010021577A (ko) 2001-03-15
ES2207853T3 (es) 2004-06-01
CN1161363C (zh) 2004-08-11
DE69818823T2 (de) 2004-05-06
BR9810561A (pt) 2000-08-15
EP0994884A1 (de) 2000-04-26
WO1999002539A1 (en) 1999-01-21
AU8806798A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
ATE224713T1 (de) Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression
PT923570E (pt) Amidas de acidos piridil-alcenoicos e piridil-alcinicos como agentes citostaticos e imunossupressivos
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE277612T1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE3751470D1 (de) Pentigetide zur Behandlung von nicht-IgE-vermittelten entzündlichen Erkrankungen.
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
ES530046A0 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
MX9304787A (es) Prodrogas de acidos de imidazolcarboxilicos y composiciones farmaceuticasque las contienen.
DE69029100D1 (de) Verwendung von Ketoconazol und ein Retinoid zur Behandlung der Akne vulgaris
DE69818823D1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE59508366D1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
ATE179594T1 (de) Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
ATE181240T1 (de) Verwendung von somatostatinanalogen zur behandlung von melanomen
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EURODRUG LTD., HONG KONG, CN

Owner name: LIPOTEC, S.A., L'HOSPITALET DE LLOBREGAT, BARCELON

8339 Ceased/non-payment of the annual fee